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Marek’s disease virus (MDV) causes an acute lymphoproliferative
disease in chickens, resulting in T cell lymphomas in visceral organs
and peripheral nerves. Earlier studies have determined that the
repeat regions of oncogenic serotype 1 MDV encode a basic leucine
zipper protein, Meq, which structurally resembles the JunFos
family of transcriptional activators. Meq is consistently expressed
in MDV-induced tumor cells and has been suggested as the MDV-
associated oncogene. To study the function of Meq, we have
generated an rMd5Meq virus by deleting both copies of the meq
gene from the genome of a very virulent strain of MDV. Growth
curves in cultured fibroblasts indicated that Meq is dispensable for
in vitro virus replication. In vivo replication in lymphoid organs and
feather follicular epithelium was also not impaired, suggesting
that Meq is dispensable for lytic infection in chickens. Reactivation
of the rMd5Meq virus from peripheral blood lymphocytes was
reduced, suggesting that Meq is involved but not essential for
latency. Pathogenesis experiments showed that the rMd5Meq
virus was fully attenuated in chickens because none of the infected
chickens developed Marek’s disease-associated lymphomas, sug-
gesting that Meq is involved in lymphocyte transformation. A
revertant virus that restored the expression of the meq gene,
showed properties similar to those of the parental virus, confirm-
ing that Meq is involved in transformation but not in lytic repli-
cation in chickens.
Herpesviruses have evolved different strategies to persist inan often hostile cellular environment. One such strategy is
to encode products that mimic cellular proteins that are able to
interact with cellular pathways, altering the host environment
to suit their own needs. Such molecular mimicries sometime go
overboard, allowing viruses to overtake the cellular pathways
resulting in oncogenic transformation. Marek’s disease virus
(MDV), a member of the Alphaherpesvirinae subfamily in the
family Herpesviridae, is one such virus. Infection with MDV
results in the induction of T cell lymphomas in chickens as early
as 3–4 weeks after infection (1). On the basis of these observa-
tions, it was speculated that the virus is likely to encode an
oncogene(s). To search for this possible oncogene(s), early
studies focused on genes expressed in tumor cells. It was shown
that transcriptional activity of MDV in tumor cells was confined
to the repeat regions (2–4). Within these regions there are
limited number of genes, including viral telomerase RNA (5),
viral IL-8 (6, 7), meq (8), pp38 (9), and ICP4 (10). Of these genes,
only Meq was consistently expressed in all MDV lymphoblast
tumor cells (7, 8) and it is present in serotype 1 strains but not
in nononcogenic serotypes 2 and 3 (11–13).
Meq is a 339-aa-long protein encoded within the MDV EcoRI
Q fragment of serotype 1 MDV strains, and thus the name Meq
(8). There are two copies of Meq in the MDV genome, one in
each of the repeats flanking the unique long regions (TRL and
IRL) (Fig. 1 and ref. 14). Meq contains domains for DNA
binding, dimerization, and transactivationrepression activities
(15, 16). The basic DNA binding and the leucine zipper regions
at the N-terminal region of Meq are closely related to the
JunFos oncoproteins, whereas the C-terminal proline-rich do-
main structurally resembles the WT-1 tumor suppressor gene
(17). The Meq protein also contains retinoblastoma binding and
RNA-binding motifs, the functional significance of which is not
fully understood (18, 19)
Due to the lack of an in vitro chicken T cell transformation
model, biological properties of Meq have been studied in a
rodent fibroblast (Rat-2) cell line. Rat-2 cells overexpressing
Meq were highly resistant to apoptosis induced by tumor necrosis
factor , C2-ceramide, UV irradiation, and serum withdrawal
(20). Overexpression of Meq in Rat-2 cells also lead to serum-
and anchorage-independent growth, and was associated with
morphological changes (20). This work was supported by Xie et
al. (21), who showed that inhibition of meq transcripts in
MDV-transformed tumor cells by antisense oligonucleotides to
meq resulted in growth inhibition, suggesting that Meq is re-
quired for maintenance of the transformed state. Although the
work cited above provides convincing evidence that, in vitro, Meq
is a multifunctional protein involved in transactivation, antiapo-
ptosis, and transformation, its role in MDV pathogenesis has not
been shown due to the difficulty in generating meq deletion
mutant.
In this report, we demonstrate the deletion of both copies of
the meq gene from a very virulent strain of MDV by using
overlapping cosmid clones (22). Pathogenesis studies in MDV-
susceptible chicken showed that Meq is not essential for cytolytic
infection in the lymphoid organs and in the feather follicular
epithelium (FFE); however, Meq is involved in transformation
of lymphocytes in vivo. In addition, inoculation of chickens with
a revertant MDV virus expressing Meq resulted in tumor
induction and pathogenesis similar to that of parental virus
confirming that Meq is the protein responsible for MDV onco-
genesis.
Materials and Methods
Cells and Viruses. Primary duck embryonic fibroblasts (DEFs)
were used for virus propagation, virus reactivation assay, and
DNA transfections. Growth curves were performed in primary
chicken embryonic fibroblasts as described (23). Recombinant
viruses were generated from cosmids derived from a very
virulent MDV strain, Md5 (24).
Cosmids. MDV cosmid clones SN5, P89, SN16, A6, and B40, from
the very virulent strain Md5 (24), encompassing the entire MDV
Abbreviations: MDV, Marek’s disease virus; FFE, feather follicular epithelium; DEF, duck
embryonic fibroblast; IFA, immunofluorescence assay; IHC, immunohistochemistry; pfu,
plaque forming units.
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genome were used to generate recombinant Md5 viruses lacking
the meq gene (ref. 22 and Fig. 1). Cosmids A6 and SN5,
containing a copy of the complete coding sequence of the MDV
unique gene meq, were used for the deletion of this gene by the
RecA-assisted restriction endonuclease cleavage method (25).
Briefly, two oligonucleotides, Meq Taq3 (5-TTT ATG TCA
GTA AAT CGA TAA ATA ATG CCT TT-3positions 5,589–
5,620 and 136,000–136,031) and Meq Taq5 (5-ACG ATC CGT
CCC CCC TCG ATC TTT CTC TCG GGT CG-3 positions
6,673–6,707 and 134,913–134,947), located at both ends of the
meq gene, were used to protect the TaqI sites (positions 5,603,
6,672, and 6,689 in SN5 cosmid and positions 134,928, 134,946,
and 136,014 in the A6 cosmid) from methylation. The protected
SN5 and A6 cosmids were methylated, by using TaqI methylase,
denatured, digested with TaqI, religated, packaged and intro-
duced into HB101 Escherichia coli cells. SN5 and A6 cosmid
clones in which the meq gene had been deleted, SN5meq and
A6meq, respectively, were identified by the loss of the 2,456-bp
EcoQ fragment after digestion with EcoRI.
Transfections. To generate a mutant virus lacking the meq gene,
rMd5meq, 500 g of NotI-digested and -purified cosmid DNA
(P89, SN16, B40, SN5Meq, and A6Meq), along with 2 g of
sheared salmon sperm DNA, were used to transfect 1.2  106
DEF cells in 60-mm dishes by the calcium phosphate procedure
as described (26). Five days after transfection, cells were
trypsinized, seeded onto a 100-mm dish, and monitored for
cytopathic effects. Viral stocks were subsequently made in DEFs
for further analysis.
Revertant Virus. To generate a revertant virus from rMd5meq
containing the meq gene, rMd5MeqR, Md5 EcoQ genomic
DNA fragment was cotransfected into DEF cells with purified
rMd5Meq viral DNA. After viral plaques were evident, trans-
fected cells were overlayed with 1.25% Bacto-Agar and har-
vested by trypsinization. Cells from each plaque were divided
into two aliquots; one was used to reinfect a fresh 60-mm dish
of DEFs, and the other was used for PCR analysis. Integration
of the meq gene into the rMd5Meq genome was detected by
PCR using primers MeqG5498 (5-GAG CCA ACA AAT CCC
CTG AC-3) and MeqL6910 (5-CTT TCG GGT CTG TGG
GTG T-3) that would generate a 1,412- or 326-bp fragment in
the rMd5MeqR and rMd5Meq, respectively.
Indirect Immunofluorescence Assay (IFA) and Immunohistochemistry
(IHC). IFA of transfected DEF cells grown on 35-mm dishes was
carried out as described (27). For IHC, lymphoid organs (thy-
mus, spleen, and bursa of Fabricius), and feather follicles of
infected and uninfected chickens were embedded in optimal
cutting temperature compound (Sakura Finetek USA, Torrance,
CA), immediately frozen in liquid nitrogen and stored at 80°C
until use. Four- to 8-m-thick cryostat sections of tissue were
prepared, fixed with cold ethanol for 5 min, and air-dried.
Immunostaining was carried out by using the Vectastain ABC kit
(Vector Laboratories) according to the manufacturer’s instruc-
tions. For IFA staining, mAb H19, specific for MDV-unique
protein pp38, was used at a working dilution of 1:300, and rabbit
serum against Meq was used at a working dilution of 1:200. For
IHC staining, monoclonal antibodies H19 and 1AN86 (specific
for MDV gB protein) were used at a working dilution of 1:3,200
and 1:2,000, respectively.
Southern Blot. rMd5 and rMd5Meq viral DNA were purified
from nucleocapsids of infected cells. Five micrograms of each
viral DNA were digested with EcoRI, separated on a 1% agarose
TBE gel, and transferred to nylon membranes. The 32P-dCTP-
labeled probes representing the complete MDV genome (SN5,
P89, SN16, A6 and B40 cosmid DNA fragments) or EcoQ
fragment (2,456-bp fragment) were generated by random prim-
ing and were used to hybridize to viral DNA, using standard
protocols.
Reactivation Assay. Buffy coats were obtained from heparinized
blood by centrifugation at 500  g for 5 min. Lymphocytes were
then counted and diluted to 106 cells per ml. For each chicken
sample, duplicated 35-mm plates of freshly seeded DEF mono-
layers were inoculated with 105 and 106 lymphocytes, and viral
plaques were counted 7 days after inoculation.
Pathogenesis Experiments. Chickens used in the studies were
MDV-susceptible F1 progeny (15  7) of the Avian Disease and
Oncology Laboratory (U.S. Department of Agriculture, East
Fig. 1. Organization of the serotype 1 MDV genome. (A) The MDV genome consists of a unique long (UL) region flanked by inverted repeats, terminal repeat
long (TRL), internal repeat long (IRL), and a unique short region (US) also flanked by inverted repeats, internal repeat short (IRS) and terminal repeat short (TRS).
(B) Schematic representation of the overlapping cosmid clones generated to reconstitute an infectious virus from a very virulent (vv) strain of MDV (Md5). The
restriction enzymes used to generate the cosmid clones and their positions are indicated. (C) Location of TaqI restriction sites in cosmids SN5 and A6 used to delete
the meq gene.
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Lansing, MI) line 15I5 males and line 71 females. These chickens
were free of maternal antibodies against MDV.
Experiment 1. To study the effect of meq deletion on cytolytic
infection, chickens were randomly sorted into experimental
groups and held in modified Horsfall–Bauer isolators for 2
weeks. One of the groups remained as a noninoculated control
group, whereas the others were inoculated s.c. with 3,000 plaque
forming units (pfu) of rMd5, rMd5meq, or rMd5MeqR at 1
day of age. Six days after inoculation, three randomly selected
chickens from each group were killed, and lymphoid organs
(thymus, bursa of Fabricius, and spleen) were collected and
examined for viral antigen expression (pp38 and gB) by IHC. To
examine in vivo virus replication during early cytolytic infection,
two chickens from control group and five chickens each from
rMd5- and rMd5meq-inoculated groups were bled on day 8
after inoculation for viremia assay. To study the effect of Meq
deletion on virus transmission, 14 days after inoculation, three
randomly selected chickens from each group were killed, and the
feather follicles were collected and examined for viral antigen
(pp38) expression by IHC.
Experiment 2. To compare the pathogenic properties of rMd5,
rMd5Meq, and rMd5MeqR, 17 susceptible chickens were
inoculated with 1,500 pfu of rMd5, rMd5Meq, or rMd5MeqR
viruses or were mock-infected at 1 day of age and raised in
isolation for 8 weeks. Weekly mortality was recorded, and all
chickens that died during the trial or were killed at the end of the
experiment (8 weeks after inoculation) were necropsied and
evaluated for MDV-specific gross tumors in the viscera and
nerves. To examine establishment of latency and reactivation,
five chickens from each experimental group were randomly
selected and bled on days 19 and 42 after inoculation for viremia
assay.
Results
Construction of Meq Deletion Mutant rMd5Meq. By using overlap-
ping cosmid clones, we have generated a mutant virus lacking
both copies of the meq gene, rMd5Meq. Plaques from recom-
binant rMd5Meq and control rMd5 viruses were evident 10–12
days after transfection. To confirm the deletion of the meq gene,
transfected cells showing plaques were examined by IFA with
mAb H19 (anti-pp38) and rabbit anti-Meq polyclonal serum. As
expected, rMd5 virus expressed both pp38 (data not shown) and
Meq, whereas rMd5Meq expressed pp38 but not Meq (Fig. 2).
To verify that rMd5Meq had the expected genome structure,
EcoRI-digested genomic DNA from rMd5 and rMd5Meq were
examined by Southern blot. These viruses showed no detectable
difference in the pattern of DNA fragments other than the Meq
region (see below), suggesting that there were no gross rear-
rangements in the rMd5Meq genome (Fig. 3, lanes 1 and 2).
Probing of the EcoRI-digested DNA with a radiolabeled Md5
EcoQ fragment resulted in 2,456 bp in rMd5 and 1,370 bp in
rMd5Meq, due to the deletion of 1,086-bp fragment of the meq
gene (Fig. 3, lanes 3 and 4). In addition, we found a 5,063-bp
fragment in rMd5Meq, which was unexpected (Fig. 3, lane 4).
Further sequence analysis of the region surrounding the meq
deletion indicated that in SN5Meq cosmid there was deletion
between two TaqI sites found at 5,603 and 9,731, instead of the
expected from 5,603 to 6,689. This action resulted in the deletion
of 4,128 bp instead of the expected 1,086 bp. This extended
deletion resulted in the loss of EcoRI site corresponding to
position 7,100, and therefore, the 1,370-bp EcoRI fragment from
the TRL migrated as a 5,063-bp fragment. Sequence analysis of
this extended deletion indicated that no other large contiguous
ORFs were deleted (14). However, because splicing and sense
antisense expression in this region is highly complex, it may affect
gene expression. The size of meq deletion in the IRL was as
expected, thus, the extended deletion in the TRL was not present
on both copies of the repeats.
In Vitro and in Vivo Replication of rMd5Meq. To determine
whether the deletion of the meq gene had any effect on
rMd5Meq in vitro growth replication, the growth rate of
rMd5Meq virus was compared with that of rMd5 by single-step
growth kinetics. Our results show that the growth characteristics
of both viruses were similar at all time points tested (days 1, 2,
Fig. 2. Immunofluorescence analysis of DEF cells infected with recombinant
viruses. Parental, rMd5, and revertant rMd5MeqR express Meq protein,
whereas the deletion mutant virus rMd5Meq does not. The presence of
rMd5Meq virus was confirmed by staining of MDV-specific pp38 protein.
Note the intranuclear expression of Meq and cytoplasmic expression of pp38.
Fig. 3. Southern blot analysis of rMd5 and rMd5Meq. DNA digested with
EcoRI and probed with total viral MDV DNA (lanes 1 and 2) or an EcoQ
(spanning meq gene)-specific probe (lanes 3 and 4) confirmed the deletion of
a 1,085-bp fragment corresponding to the Meq gene (lane 4) and the absence
of gross rearrangement in the viral genome (lanes 1 and 2). The band corre-
sponding to the 5,063-bp fragment is explained in Results.
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3, 4, and 5; data not shown) indicating that although Meq is
expressed in MDV-infected cells, it is dispensable for in vitro
growth.
To examine whether Meq plays a role in in vivo replication,
MDV maternal antibody-negative chickens were inoculated with
rMd5 or rMd5Meq viruses at 1 day of age. Six days after
inoculation, three randomly selected chickens from each group
were killed, and lymphoid organs (thymus, bursa of Fabricius,
and spleen) were collected and examined for viral antigen
expression (pp38) by IHC. As seen in Fig. 4, there was a high
level of expression of pp38 in the lymphoid organs of rMd5 and
rMd5Meq-inoculated chickens. To confirm that Meq deletion
had no effect in viral replication, sections of lymphoid organs
were also stained for gB, envelope glycoprotein expression. The
results obtained confirm the data obtained with pp38 (data not
shown) indicating that Meq is not essential for early cytolytic
infection in lymphoid organs. However, virus isolation on day 8,
from buffy coat cells isolated from rMd5 and rMd5Meq-
inoculated chickens indicated that there was a reduction of virus
titer in rMd5Meq group compared with parental rMd5 group
(Table 1). An average of 300 pfu were recovered from the
rMd5-inoculated group compared with 100 pfu from the
rMd5Meq-inoculated group when 106 lymphocytes were plated
on DEFs. Virus titers at this early phase of infection are likely
to reflect cytolytic infection in lymphocytes.
Transmission of rMd5Meq. Transmission of MDV takes place
after replication of virus in the FFE and release of infectious
virus in the dander. The virus shed through the dander is
extremely stable in the environment and serves as a source of
infection (28). To examine whether Meq is necessary for virus
replication in FFE, three randomly selected chickens from each
group were killed, and the feather follicles were examined for
viral antigen (pp38) expression by IHC. As shown in Fig. 4, both
rMd5 and rMd5Meq viruses had similar levels of pp38 expres-
sion in the feather follicles, indicating that Meq is not essential
for secondary replication in the FFE, and presumably, for
horizontal transmission.
Latency and Reactivation of rMd5Meq. To examine whether Meq
is involved in establishment of latency and reactivation, periph-
eral blood lymphocytes (buffy coat) isolated from chickens on
days 19 and 42 were cocultivated with DEFs. As shown in Table
1, there was significantly lower virus recovery in rMd5Meq
compared with rMd5 virus at both time points tested. On day 19,
an average of 60 pfu were recovered from rMd5Meq compared
with 303 pfu from rMd5-inoculated chickens (five per group).
Similarly, on day 42, an average of only 3 pfu were recovered
from rMd5Meq compared with 143 pfu from rMd5-inoculated
chickens (five per group). This reduced recovery of virus from
peripheral blood lymphocytes from later stages of infection
suggested that Meq might be involved in establishment of latency
andor reactivation.
Oncogenicity of rMd5Meq. To determine whether the deletion of
meq gene affects the pathogenic properties of MDV, chickens
inoculated with rMd5 or rMd5Meq were observed for mortal-
ity for a period of 8 weeks. All chickens that died during the
experiment or at termination were examined for MDV-specific
lesion, including gross tumors and nerve lesions. As indicated in
Fig. 5, one chicken from mock-infected and rMd5Meq groups
died on day 8 due to nonspecific causes. MDV-associated
mortality was observed in parental rMd5 group starting at 4
weeks after infection and only one chicken survived the duration
of the experiment. There was no MDV-associated mortality in
mock- or rMd5Meq-inoculated groups. All the chickens in the
rMd5 group had gross MDV-specific lesion, whereas none were
observed in either rMd5Meq- or mock-inoculated groups
(Table 2). In addition, as in the mock-infected control group, no
atrophy of the bursa of Fabricius and thymus was observed in
rMd5Meq group compared with massive atrophy in the rMd5
group (data not shown). It was interesting to note that even
though there was robust early cytolytic infection in rMd5Meq,
the lymphoid organs were not atrophied. These data indicate
Fig. 4. Immunohistochemical analysis of lymphoid organs at 6 days (bursa,
spleen, and thymus) and FFE at 14 days after inoculation of rMd5, rMd5meq,
and control chickens. Frozen sections were stained with pp38-specific mAb.
Table 1. Virus reactivation from peripheral blood lymphocytes
Virus Day 8 Day 19 Day 42
rMd5 200, 245, 293,
407, 371
250, 268, 384,
470, 250
106, 232, 90*
rMd5Meq 92, 85, 116,
117, 91
10, 21, 42,
194, 31
8, 2, 2, 1, 4
rMd5MeqR ND 312, 546, 225,
208, 310
91*
None 0, 0 0, 0, 0, 0, 0 0, 0
Reactivation assays were performed on days 8, 19, and 42 after inoculation.
The numbers represent the average number of pfu observed on day 7, when
106 peripheral blood lymphocytes were cultured on DEF. Chickens assayed on
day 8 are from experiment 1, which received 3,000 pfu, whereas chickens
assayed on days 19 and 42 are from experiment 2, which received 1,500 pfu at
1 day of age.
*Tested fewer than five chickens per group because of mortality.
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that the deletion of the meq gene significantly decreases the
virulence of the recombinant rMd5Meq.
Construction and Biological Properties of Revertant Virus
rMd5MeqR. To verify that the phenotypic changes observed in
the pathogenesis of rMd5Meq were only due to the deletion of
meq, we generated a revertant virus, rMd5MeqR, by cotrans-
fection of rMd5Meq viral DNA with EcoQ fragment, contain-
ing the meq gene. Revertant viruses were selected by plaque
purification and screened for the presence of the meq gene by
PCR. In addition, expression of Meq in rMd5MeqR-infected
cells was confirmed by IFA (Fig. 2). As shown in Table 2, the
pathogenic properties of the revertant rMd5MeqR virus were
fully restored, and tumors were observed in 100% of the
inoculated chickens. The data indicate that the mortality in
chickens started at 4 weeks and all of the chickens inoculated
with rMd5MeqR died before the end of the experiment (8
weeks; Fig. 5). These results confirm our observation that Meq
plays an important role in MDV pathogenesis.
Discussion
MDV is a highly contagious herpesvirus, which elicits a rapid
onset of malignant T cell lymphomas in chicken, usually within
weeks after infection (1). Meq is the only protein persistently
expressed in MDV tumors and MDV transformed T lymphoblast
cell lines (8), and is thus likely to play a regulatory role in latency
and transformation. Meq, a basic leucine zipper protein, asso-
ciates with high affinity with a number of basic leucine zipper
proteins like itself, c-Jun, JunB, ATF2, and Fos (29), and with
less affinity to CREB, ATF1, ATF3, and CEBP. The DNA-
binding sequences of Meq homodimers and MeqJun het-
erodimers have been identified by cyclic amplification of selected
targets (15) and confirmed by chromosomal immunoprecipita-
tion techniques (30). Meq-binding sites are enriched in three
regions of the MDV genome: the Meq promoter, ICP4 pro-
moter, and the MDV origin of replication (or pp24pp38
promoter). Transactivation studies with this DNA-recognition
sites have shown that the MeqJun heterodimers transactivate
the Meq promoter, whereas the Meq homodimers repress the
pp14pp38 promoter, indicating that Meq may play a role in
latency and replication.
It is known that at 7–8 days after infection, or slightly later,
MDV infection in the chicken lymphoid organs switches from
productive to latent phase (1). Viremia, a latent infection of
peripheral blood lymphocytes, can be detected by cocultivation
of latently infected lymphocytes with fibroblasts. Therefore, viral
titers measured beyond the 7–8 days after infection, are likely
due to reactivation of virus from latently infected lymphocytes.
Our in vivo experiments with the MDV Meq deletion virus
showed that whereas the virus replicated at the parental rMd5
level during the early cytolytic infection (Fig. 4), virus reactiva-
tion measured at 8 and 19 days after infection was reduced by 3-
and 5-fold respectively, compared with parental rMd5 levels
(Table 1). These results indicate that Meq is dispensable for early
cytolytic infection and supports previous hypothesis that Meq
plays a role, but is not essential for latency andor reactivation.
There is strong supportive evidence that Meq is an oncogene.
Overexpression of Meq in a rodent fibroblast cell line (Rat-2)
resulted in transformation, serum- and anchorage-independent
growth, morphological changes, shortened G1 phase, and resis-
tance to apoptosis-inducing factors (31). Overexpression of Meq
in an immortalized chicken embryo fibroblast cell line (DF-1)
gave similar results (A. M. Levy and H.-J.K., unpublished
results), reinforcing the notion that Meq is an oncogene. In vivo
experiments with the rMd5Meq virus confirm that Meq is the
MDV-associated oncogene. Whereas the rMd5Meq virus did
not induce any tumors in MDV-susceptible chickens, inoculation
with parental or revertant viruses resulted in 100% Marek’s
disease. Histological examination of vagus and sciatic nerves
(data not shown) confirmed the absence of MDV-associated
tumor cells in rMd5Meq virus-infected chickens, reaffirming
that Meq is essential for transformation of lymphocytes. It has
been documented that reduction or absence of early cytolytic
infection correlates with absence or reduction of lymphomas
(32–34). Because the rMd5Meq virus was not impaired for
early cytolytic infection, as observed by viral antigen expression
(pp38 and gB) in lymphoid organs at 6 days after inoculation
(Fig. 4), the loss of transformation observed is likely to be
attributed to the transforming capability of Meq. Although it
could be argued that the loss of transformation is a consequence
of the reduction in viremia of the rMd5Meq virus (Table 1),
this is unlikely because pp38 (ref. 22 and S.M.R., unpublished
results) and viral IL-8 (6, 35) null mutant viruses, which also
present reduced viremia titers, are still able to induce transfor-
mation. Lack of oncogenicity of rMd5Meq is reiterated by
experiments with RB1Bmeqlac, a mutant independently con-
structed by the marker rescue technique in the background of the
very virulent RB1B isolate. The RB1Bmeqlac mutant failed to
cause tumors in chickens exposed to it by inoculation (031) or
by contact (021), whereas the parent RB1B strain readily
induced tumors in both inoculates (2129) and contact-exposed
chickens (1122). Therefore, the observation that the
Fig. 5. Incidence of mortality in chickens inoculated with rMd5, rMd5Meq,
and rMd5MeqR. Chickens were inoculated with 1,500 pfu of the indicated
viruses at 1 day of age and maintained in isolation for 8 weeks. Uninoculated
chickens served as negative controls. Weekly mortality was recorded. Chickens
that died during the experiment were evaluated for MDV-specific gross
lesions. One chicken from mock-infected and rMd5Meq groups died on day
8 due to nonspecific causes.
Table 2. Marek’s disease in MDV maternal
antibody-negative chickens
Virus*
No. of chickens that
diedno. tested, %
No. of chickens with
tumors†no. tested, %
rMd5 1617 (94.1) 1717 (100)
rMd5Meq 117 (5.9)‡ 017 (0)
rMd5MeqR 1717 (100) 1717 (100)
None 117 (5.9)‡ 017 (0)
*All chickens were inoculated with 1,500 pfu of the indicated virus by subcu-
taneous route.
†Tumors indicate gross visible MDV-specific lymphoid tumors in visceral organs
or nerves.
‡One chicken from rMd5Meq and uninoculated groups died at day 8 due to
nonspecific causes.
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rMd5Meq and RB1Bmeqlac mutant viruses have no oncoge-
nicity, argues strongly for the role of Meq in transformation.
It has recently been shown that Meq is able to transform
immortalized chicken cells by activating the JunAP-1 pathway,
and in MDV-transformed T cells, Meq and Jun are corecruited
to the AP-1 site of the chicken IL-2 promoter, suggesting that a
functional role of Meq is activating the IL-2 autocrine loop (30).
These data, together with those presented here, suggest that Meq
contributes to MDV oncogenesis by facilitating latency entry
reactivation and by mediating transformation of the target cells.
This report provides, to our knowledge, the first conclusive
evidence that Meq is involved in MDV-associated transforma-
tion of lymphocytes in chickens. Future studies are needed to
elucidate various functions of Meq by generating recombinant
viruses with subtle mutations in the meq gene. The data pre-
sented here, as well as future studies with MDV Meq protein,
may shed light on the role of basic leucine zipper proteins on the
biology of Epstein–Barr virus and Kaposi’s sarcoma-associated
herpesvirus, two human herpesviruses of the Gammaherpesviri-
nae subfamily (36–38).
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